Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ping An Insurance | Shanghai | Financial | Insurance | CN¥966.40B | 8.1x | 0.2 | CN¥53.28 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.9% Upside | Upgrade to Pro+ | |
China Life Insurance A | Shanghai | Financial | Insurance | CN¥911.85B | 3.3x | 0.06 | CN¥38.29 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2% Downside | Upgrade to Pro+ | |
China Pacific Insurance | Shanghai | Financial | Insurance | CN¥333.15B | 7.8x | 0.12 | CN¥34.43 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.8% Upside | Upgrade to Pro+ | |
People's Insurance | Shanghai | Financial | Insurance | CN¥329.41B | 4.3x | 0.05 | CN¥8.27 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.1% Downside | Upgrade to Pro+ | |
COFCO Capital Holdings | Shenzhen | Financial | Insurance | CN¥26.50B | 39.7x | -0.7 | CN¥11.50 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hubei Biocause Pharmaceutical | Shenzhen | Financial | Insurance | CN¥13.44B | -18.3x | 0.06 | CN¥2.74 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangxi Tianli Technology INC | Shenzhen | Financial | Insurance | CN¥4.68B | 197.5x | -66.9 | CN¥23.70 | -6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |